Bilateral risk-reducing nipple-sparing mastectomy with implant-based reconstruction after previous breast-conserving treatment including radiotherapy: an exploratory multicenter cohort study
22 affiliations
- 1Hospital Geral de Fortaleza, R. Ávila Goularte, 900, Fortaleza, 60150160 Brazil
- 2Brazilian Breast Cancer Association Team, São Paulo, Brazil
- 3Hospital do Servidor Público Estadual Francisco Morato de Oliveira, São Paulo, Brazil
- 4Hospital Israelita Albert Einstein, São Paulo, Brazil
- 5Barretos Cancer Hospital, Barretos, Brazil
- 6Universidade Estadual de Campinas, Campinas, Brazil
- 7Hospital Salvalus, Hapvida NotreDame Intermédica, São Paulo, Brazil
- 8Oncoclinicas Group, São Paulo, Brazil
- 9Santa casa de misericórdia de São Paulo, São Paulo, Brazil
- 10Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil
- 11Americas Oncologia, Rio de Janeiro, Brazil
- 12Hospital da Mulher, São Paulo, Brazil
- 13Grupo Orizonti, Belo Horizonte, Brazil
- 14Hospital Ipiranga, São Paulo, Brazil
- 15Hospital do Câncer de Muriaé da Fundação Cristiano Varella, Muriaé, Brazil
- 16School of Medicine, Federal University of Paraná, Curitiba, Brazil
- 17Centro de Mama Santa Casa e Oncologia Hospital Nora Teixeira, Porto Alegre, Brazil
- 18Medical Oncology Center, Hospital Sírio-Libanês, Brasília, Brazil
- 19Grupo Américas, Hospital Paulistano, São Paulo, Brazil
- 20Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
- 21Instituto D’or de Ensino e Pesquisa, Salvador, Brasil
- 22Rede Americas Oncology, Brasília, Brazil
Abstract
Background: Nipple-sparing mastectomy (NSM) with implant-based reconstruction is increasingly used in prophylactic settings. Outcomes after previous breast-conserving treatment (BCT) including radiotherapy remain uncertain.
Methods: This exploratory retrospective multicenter cohort included asymptomatic patients with pathogenic germline mutations who underwent bilateral risk-reducing NSM with immediate implant-based reconstruction at 12 Brazilian institutions. The exposure was previous BCT including radiotherapy, rather than radiotherapy alone. The primary outcome was the occurrence of at least one early postoperative complication. Secondary outcomes included capsular contracture, additional reconstructive procedures, descriptive burden of complication events and retrospectively assessed aesthetic outcomes. Analyses were performed at the patient level. Modified Poisson regression with robust variance was used in an exploratory adjusted analysis.
Results: Among 219 patients, 20 (9.1%) had previous BCT including radiotherapy. Early postoperative complications occurred in 5/20 exposed patients (25.0%) and 47/199 unexposed patients (23.6%; p = 0.88). The descriptive event-based rates were 0.50 and 0.26 early complication events per patient in the exposed and unexposed groups, respectively; this analysis was descriptive only and no inferential comparison was performed. In the exploratory adjusted analysis, previous BCT including radiotherapy was not associated with early postoperative complications (adjusted RR 0.64, 95% CI 0.16–2.60; p = 0.53), although the estimate was imprecise. No statistically significant differences were detected in capsular contracture or the ordinal aesthetic assessment. Additional procedures included planned and elective aesthetic-reconstructive interventions and were not interpreted as complication-related reoperations. Aesthetic findings were limited by retrospective institutional assessment and missing data, particularly in the unexposed group.
Conclusions: In this exploratory patient-level multicenter cohort, no statistically significant increase in complications was detected among carefully selected mutation carriers with previous BCT including radiotherapy. However, clinically relevant differences cannot be excluded because of the small, exposed cohort, retrospective selection, patient-level analysis, potential breast-level exposure misclassification, missing aesthetic data, and wide confidence intervals. These findings should be hypothesis-generating.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12893-026-04148-9.
Related
- Advances in Implant-Based Breast Reconstruction in the Setting of Post-Mastectomy Radiotherapy
- Biopsy of Secondary Angiosarcoma Arising in Native Mastectomy Skin of a Reconstructed Breast Without Prior Radiotherapy
- Long-term oncological outcomes after nipple-sparing mastectomy and implant-based immediate breast reconstruction in a population-based cohort of breast cancer patients
- Comparison of surgical outcomes, safety, and cosmetic satisfaction between immediate implant-based and transverse rectus abdominis myocutaneous (TRAM) flap breast reconstruction following total mastectomy: a retrospective cohort study
- Long-term implant integrity and complications after risk-reducing mastectomy with immediate implant reconstruction: a retrospective cohort study with prospective ultrasound follow-up at a Swedish university hospital
BibTeX
@article{cavalcante2026bilateral,
title = {{Bilateral risk-reducing nipple-sparing mastectomy with implant-based reconstruction after previous breast-conserving treatment including radiotherapy: an exploratory multicenter cohort study}},
author = {Francisco Pimentel Cavalcante and Marcelo Antonini and Antonio L. Frasson and Idam de Oliveira-Junior and Fabricio P. Brenelli and Anastasio Berrettini Junior and Guilherme N. Garcia and Fabio Bagnoli and Felipe P. Zerwes and Eduardo C. Millen and André Mattar and João H. P. Reis and Rogerio Fenile and Rene A. C. Vieira and Helio R. de Oliveira Filho and Martina Lichtenfels and Renata L. Sandoval and Pedro L. S. Quidute and Renato Z. Torresan and Lucia M. M. Zuliani and Marcela M. Bortoluzzi and Anne D. N. Lima and Rodrigo S. C. Guindalini and Natalia Polidorio},
journal = {BMC Surgery},
year = {2026},
month = aug,
doi = {10.1186/s12893-026-04148-9},
url = {https://doi.org/10.1186/s12893-026-04148-9},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Bilateral risk-reducing nipple-sparing mastectomy with implant-based reconstruction after previous breast-conserving treatment including radiotherapy: an exploratory multicenter cohort study
AU - Francisco Pimentel Cavalcante
AU - Marcelo Antonini
AU - Antonio L. Frasson
AU - Idam de Oliveira-Junior
AU - Fabricio P. Brenelli
AU - Anastasio Berrettini Junior
AU - Guilherme N. Garcia
AU - Fabio Bagnoli
AU - Felipe P. Zerwes
AU - Eduardo C. Millen
AU - André Mattar
AU - João H. P. Reis
AU - Rogerio Fenile
AU - Rene A. C. Vieira
AU - Helio R. de Oliveira Filho
AU - Martina Lichtenfels
AU - Renata L. Sandoval
AU - Pedro L. S. Quidute
AU - Renato Z. Torresan
AU - Lucia M. M. Zuliani
AU - Marcela M. Bortoluzzi
AU - Anne D. N. Lima
AU - Rodrigo S. C. Guindalini
AU - Natalia Polidorio
PY - 2026
DA - 2026/08/17
JO - BMC Surgery
DO - 10.1186/s12893-026-04148-9
UR - https://doi.org/10.1186/s12893-026-04148-9
AB - Background: Nipple-sparing mastectomy (NSM) with implant-based reconstruction is increasingly used in prophylactic settings. Outcomes after previous breast-conserving treatment (BCT) including radiotherapy remain uncertain. Methods: This exploratory retrospective multicenter cohort included asymptomatic patients with pathogenic germline mutations who underwent bilateral risk-reducing NSM with immediate implant-based reconstruction at 12 Brazilian institutions. The exposure was previous BCT including radiotherapy, rather than radiotherapy alone. The primary outcome was the occurrence of at least one early postoperative complication. Secondary outcomes included capsular contracture, additional reconstructive procedures, descriptive burden of complication events and retrospectively assessed aesthetic outcomes. Analyses were performed at the patient level. Modified Poisson regression with robust variance was used in an exploratory adjusted analysis. Results: Among 219 patients, 20 (9.1%) had previous BCT including radiotherapy. Early postoperative complications occurred in 5/20 exposed patients (25.0%) and 47/199 unexposed patients (23.6%; p = 0.88). The descriptive event-based rates were 0.50 and 0.26 early complication events per patient in the exposed and unexposed groups, respectively; this analysis was descriptive only and no inferential comparison was performed. In the exploratory adjusted analysis, previous BCT including radiotherapy was not associated with early postoperative complications (adjusted RR 0.64, 95% CI 0.16–2.60; p = 0.53), although the estimate was imprecise. No statistically significant differences were detected in capsular contracture or the ordinal aesthetic assessment. Additional procedures included planned and elective aesthetic-reconstructive interventions and were not interpreted as complication-related reoperations. Aesthetic findings were limited by retrospective institutional assessment and missing data, particularly in the unexposed group. Conclusions: In this exploratory patient-level multicenter cohort, no statistically significant increase in complications was detected among carefully selected mutation carriers with previous BCT including radiotherapy. However, clinically relevant differences cannot be excluded because of the small, exposed cohort, retrospective selection, patient-level analysis, potential breast-level exposure misclassification, missing aesthetic data, and wide confidence intervals. These findings should be hypothesis-generating. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12893-026-04148-9.
SN - 1471-2482
ER -